More about

Prostate Cancer

News
October 08, 2022
2 min read
Save

Rucaparib extends PFS in advanced prostate cancer

Rucaparib extends PFS in advanced prostate cancer

A randomized phase 3 trial that assessed rucaparib for certain men with advanced prostate cancer met its primary endpoint of improved PFS, according to topline data released by the agent’s manufacturer.

News
October 06, 2022
3 min read
Save

Genetic variants linked to aggressive prostate cancer in men of African ancestry

Genetic variants linked to aggressive prostate cancer in men of African ancestry

Researchers have identified genetic variants in prostate tumors of men of African descent that appear to be associated with African ancestry.

News
September 22, 2022
2 min read
Save

Long-course ADT plus radiotherapy provides survival benefit after prostatectomy

Long-course ADT plus radiotherapy provides survival benefit after prostatectomy

Long-course androgen depravation therapy extended metastasis-free survival compared with short-course ADT when added to radiotherapy after radical prostatectomy, results of the randomized phase 3 RADICALS-HD trial showed.

News
September 08, 2022
3 min read
Save

Single-port robotic system for prostatectomy ‘has made a huge difference,’ surgeon says

Single-port robotic system for prostatectomy ‘has made a huge difference,’ surgeon says

Smilow Cancer Hospital has introduced a new single-port robotic prostatectomy procedure that reduces the number of incisions and may minimize the risk for complications.

News
September 01, 2022
1 min read
Save

Top in hem/onc: Risk of alcohol-associated cancer; adverse events in prostate cancer

Top in hem/onc: Risk of alcohol-associated cancer; adverse events in prostate cancer

A Korean study published in JAMA Network Open found that individuals who increased their alcohol consumption were at higher risk for both alcohol-associated and all cancer types.

News
August 26, 2022
2 min read
Save

Genetic counseling relatively low cost, ‘should be offered to more at-risk patients’

Genetic counseling relatively low cost, ‘should be offered to more at-risk patients’

Submitted medical claims and out-of-pocket costs for genetic counseling encounters appeared relatively low among patients with certain cancer types, according to a research letter published in JAMA Health Forum.

News
August 24, 2022
3 min read
Save

Common prostate cancer drugs may elevate risk for metabolic, cardiovascular adverse events

Common prostate cancer drugs may elevate risk for metabolic, cardiovascular adverse events

Both abiraterone and enzalutamide appeared to increase risk for metabolic and cardiovascular adverse events among older men with advanced prostate cancer who previously underwent androgen deprivation therapy, according to study results.

News
August 23, 2022
1 min read
Save

Metformin, testosterone therapies lower risk for certain hormone-related cancers in men

Metformin, testosterone therapies lower risk for certain hormone-related cancers in men

In a large cohort of men, pre‐diagnostic use of metformin and testosterone replacement therapy was associated with lower incidence of prostate and colorectal cancers, but not male breast cancer, according to research.

News
August 21, 2022
2 min read
Save

CV admission rates increase among patients with cancer

CV admission rates increase among patients with cancer

Rates for CV admissions among patients with cancer has increased, according to a study published in the European Heart Journal Quality of Care & Clinical Outcomes.Primary CV admissions are highest among patients with hematological cancer with the most common cause of admission being heart failure, according to the study.

News
August 16, 2022
1 min read
Save

FDA grants priority review to Lynparza regimen for advanced prostate cancer

FDA grants priority review to Lynparza regimen for advanced prostate cancer

The FDA granted priority review to olaparib as part of combination therapy treatment of metastatic castration-resistant prostate cancer.

View more